Genmab — Juni 2018
-
Secondly, and perhaps more worryingly, the committee’s report stated that there was a marked increase in “mortality-related events.” This suggests that not only was Darzalex not effective in treating the cancer, but it was actually potentially causing harm to the patients.
-
Stockbull...De spekulationer har også været nævnt andre steder lige efter meddelelsen om stoppet kom.
-
Også kan man tænke over hvorfor CHMP lægger begrænsninger på brugen af Keytruda og Tecentriq i hver deres kombinationer. Mon ikke trickeren der trækker i den gale retning ligeså godt være i Tecentriq. Det gør kun BMS-studierne med Dara mere spændende
-
-
http://www.multiplemyelomahub.com/medical-information/philippe-moreau-asco-2018-critical-trials-in-mm-that-could-change-clinical-practice Philippe Moreau | ASCO 2018 | Critical trials in MM that could change clinical practice
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind